XBiotech Inc. (XBIT) income statement
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.73+0.05 (+2.98%)
Close on Nov 20, 2026Market cap $52.74MP/E –Yield –
XBiotech Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $52.74MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||||
| Gross margin | – | – | – | 83.8% | 68.4% | 21.5% | – | – | – | – | – | – | – | – |
| Operating margin | – | – | – | -860.1% | -136.4% | -41.5% | – | – | – | – | – | – | – | – |
| Pre-tax margin | – | – | – | -837.6% | -138.4% | -29.2% | – | – | – | – | – | – | – | – |
| Net profit margin | – | – | – | -820.4% | -94.7% | -25.5% | – | – | – | – | – | – | – | – |
| Free cash flow margin | – | – | – | -384.3% | 358.4% | -156.5% | – | – | – | – | – | – | – | – |
| Effective tax rate | – | – | – | – | – | – | 6.9% | – | – | – | – | – | – | – |
| Returns on capital | ||||||||||||||
| Return on equity | -28.2% | -19.2% | -10.7% | -12.9% | -5.6% | -2.0% | 167.8% | -41.6% | -55.6% | -65.1% | -46.3% | -62.7% | -112.8% | – |
| Return on assets | -26.1% | -18.1% | -10.4% | -12.6% | -5.5% | -1.9% | 155.3% | -39.4% | -51.0% | -59.8% | -43.7% | -34.9% | – | – |
| Return on tangible assets | -26.1% | -18.1% | -10.4% | -12.6% | -5.5% | -1.9% | 155.3% | -39.4% | -51.0% | -59.8% | -43.7% | -34.9% | – | – |
| Return on capital employed | -34.1% | -21.0% | -16.2% | -13.4% | -8.1% | -3.3% | -7.8% | -41.3% | -57.1% | -65.1% | -46.3% | -36.9% | – | – |
| NOPAT | -$43.99M | -$33.55M | -$29.63M | -$27.25M | -$19.81M | -$14.44M | -$29.07M | -$16.59M | -$26.91M | -$41.68M | -$29.63M | -$17.20M | -$7.84M | – |
| Cash flow quality | ||||||||||||||
| OCF / Sales | – | – | – | -369.7% | 377.5% | -148.1% | – | – | – | – | – | – | – | – |
| OCF / Net income | 0.88 | 0.80 | 0.76 | 0.45 | -3.99 | 5.81 | -0.03 | 0.78 | 1.02 | 0.87 | 0.89 | 0.54 | 0.90 | – |
| FCF / OCF | 100.7% | 104.2% | 101.9% | 103.9% | 94.9% | 105.7% | 101.1% | 100.7% | 104.2% | 110.3% | 107.0% | 111.9% | 100.7% | – |
| FCF / Net income | 0.88 | 0.84 | 0.78 | 0.47 | -3.79 | 6.14 | -0.03 | 0.79 | 1.06 | 0.96 | 0.95 | 0.60 | 0.90 | – |
| Unlevered free cash flow | -$40.21M | -$32.27M | -$19.09M | -$15.41M | $65.92M | -$68.88M | -$18.47M | -$16.66M | -$35.05M | -$50.76M | -$35.63M | -$13.10M | -$8.97M | – |
| Levered free cash flow | -$40.21M | -$32.27M | -$19.09M | -$15.41M | $65.92M | -$68.88M | -$18.47M | -$16.66M | -$35.05M | -$50.76M | -$35.63M | -$13.10M | -$8.97M | – |
| Efficiency | ||||||||||||||
| Asset turnover | – | – | 0.00 | 0.02 | 0.06 | 0.08 | 0.00 | 0.00 | – | – | – | – | – | – |
| Fixed asset turnover | – | – | 0.00 | 0.15 | 0.66 | 1.68 | 0.00 | 0.00 | – | – | – | – | – | – |
| Receivables turnover | – | – | 0.00 | 6.60 | 8.94 | 21.39 | – | – | – | – | – | – | – | – |
| Days sales outstanding | – | – | – | 55.3 | 40.8 | 17.1 | – | – | – | – | – | – | – | – |
| Payables turnover | – | – | 0.00 | 0.29 | 2.55 | 14.89 | 0.00 | 0.00 | – | – | – | – | – | – |
| Days payables outstanding | – | – | – | 1,255.1 | 143.0 | 24.5 | – | – | – | – | – | – | – | – |
| CapEx to revenue | – | – | – | 14.6% | 19.2% | 8.5% | – | – | – | – | – | – | – | – |
| CapEx to OCF | -0.72% | -4.2% | -1.9% | -3.9% | 5.1% | -5.7% | -1.1% | -0.74% | -4.2% | -10.3% | -7.0% | -11.9% | -0.66% | – |
| Liquidity | ||||||||||||||
| Current ratio | 16.01 | 11.56 | 33.07 | 54.07 | 71.49 | 81.80 | 11.90 | 5.78 | 11.94 | 4.64 | 14.79 | 18.45 | – | – |
| Quick ratio | 16.01 | 11.56 | 33.07 | 54.07 | 71.49 | 81.80 | 11.90 | 5.78 | 11.94 | 4.64 | 14.79 | 18.45 | – | – |
| Cash ratio | 15.83 | 11.43 | 32.79 | 53.49 | 68.63 | 59.58 | 11.87 | 5.37 | 11.38 | 4.31 | 14.47 | 18.22 | – | – |
| Working capital | $119.02M | $159.46M | $195.62M | $215.78M | $243.42M | $321.89M | $656.07M | $14.07M | $30.54M | $28.97M | $86.75M | $54.92M | – | – |
| Net current asset value | $117.22M | $157.74M | $193.95M | $214.14M | $241.08M | $320.77M | $655.02M | $14.07M | $30.52M | $28.94M | $86.73M | $54.92M | – | – |
| Leverage | ||||||||||||||
| Assets to equity | 1.07 | 1.09 | 1.04 | 1.02 | 1.02 | 1.01 | 1.08 | 1.07 | 1.05 | 1.14 | 1.06 | 1.05 | – | – |
| Per share | ||||||||||||||
| Revenue per share | – | – | 0.00 | 0.13 | 0.60 | 1.50 | 0.00 | 0.00 | – | – | – | – | – | – |
| EPS (basic) | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 | -0.36 | 17.17 | -0.59 | -0.95 | -1.63 | -1.22 | -0.90 | -0.45 | – |
| EPS (diluted) | -1.49 | -1.26 | -0.81 | -1.08 | -0.58 | -0.36 | 14.44 | -0.59 | -0.95 | -1.63 | -1.22 | -0.90 | -0.45 | – |
| Book value per share | 4.60 | 5.98 | 7.19 | 7.90 | 8.85 | 11.90 | 18.20 | 1.15 | 1.70 | 1.81 | 3.19 | 2.14 | 0.46 | – |
| Tangible book value per share | 4.60 | 5.98 | 7.19 | 7.90 | 8.85 | 11.90 | 18.20 | 1.15 | 1.70 | 1.81 | 3.19 | 2.14 | 0.46 | – |
| Cash per share | 4.12 | 5.66 | 6.57 | 7.14 | 7.79 | 8.10 | 17.21 | 0.44 | 0.90 | 1.05 | 2.82 | 2.08 | 0.33 | – |
| Operating cash flow per share | -1.31 | -1.02 | -0.62 | -0.49 | 2.28 | -2.22 | -0.44 | -0.46 | -0.95 | -1.41 | -1.03 | -0.42 | -0.40 | – |
| Free cash flow per share | -1.32 | -1.06 | -0.63 | -0.51 | 2.17 | -2.35 | -0.44 | -0.46 | -0.99 | -1.56 | -1.10 | -0.48 | -0.40 | – |
| CapEx per share | 0.0095 | 0.04 | 0.01 | 0.02 | 0.12 | 0.13 | 0.0049 | 0.0034 | 0.04 | 0.15 | 0.07 | 0.05 | 0.0027 | – |
| Valuation at period end | ||||||||||||||
| Market cap | $72.87M | $120.39M | $121.75M | $106.84M | $338.33M | $457.36M | $766.51M | $181.96M | $139.62M | $328.33M | $348.42M | – | – | – |
| Enterprise value | -$74.50M | -$62.72M | -$80.44M | -$113.26M | $99.45M | $218.93M | $726.17M | $161.12M | $100.65M | $281.54M | $242.74M | – | – | – |
| P/E | – | – | – | – | – | – | 1.1x | – | – | – | – | – | – | – |
| P/S | – | – | – | 26.6x | 18.4x | 10.4x | – | – | – | – | – | – | – | – |
| P/B | 0.5x | 0.7x | 0.6x | 0.4x | 1.3x | 1.3x | 1.0x | 4.4x | 2.3x | 5.6x | 3.4x | – | – | – |
| P/TBV | 0.5x | 0.7x | 0.6x | 0.4x | 1.3x | 1.3x | 1.0x | 4.4x | 2.3x | 5.6x | 3.4x | – | – | – |
| P/Gross profit | – | – | – | 31.8x | 26.9x | 48.4x | – | – | – | – | – | – | – | – |
| P/OCF | -1.8x | -3.9x | -6.5x | -7.2x | 4.9x | -7.0x | -42.0x | -11.0x | -4.1x | -7.1x | -10.5x | – | – | – |
| P/FCF | – | – | – | – | 5.1x | – | – | – | – | – | – | – | – | – |
| EV/Sales | – | – | – | -28.2x | 5.4x | 5.0x | – | – | – | – | – | – | – | – |
| EV/Gross profit | – | – | – | -33.7x | 7.9x | 23.2x | – | – | – | – | – | – | – | – |
| EV/EBIT | 1.3x | 1.5x | 2.1x | 3.3x | – | – | – | – | – | – | – | – | – | – |
| EV/OCF | 1.9x | 2.0x | 4.3x | 7.6x | 1.4x | -3.4x | -39.7x | -9.7x | -3.0x | -6.1x | -7.3x | – | – | – |
| EV/FCF | 1.9x | 1.9x | 4.2x | 7.4x | 1.5x | – | – | – | – | – | – | – | – | – |
| Earnings yield | -62.5% | -32.0% | -20.2% | -30.8% | -5.1% | -2.5% | 87.2% | -11.6% | -23.7% | -16.1% | -10.8% | – | – | – |
| FCF yield | -55.2% | -26.8% | -15.7% | -14.4% | 19.5% | -15.1% | -2.4% | -9.2% | -25.1% | -15.5% | -10.2% | – | – | – |
| Shareholder yield | ||||||||||||||
| Payout ratio | – | – | – | -0.00% | -430.7% | -0.00% | 0.00% | – | – | – | – | – | – | – |
| FCF payout ratio | – | – | – | -0.00% | 113.8% | -0.00% | -0.00% | – | – | – | – | – | – | – |
| Buyback yield | – | 0.00% | 0.01% | 0.00% | – | – | – | – | – | – | – | – | – | – |
| Shareholder yield | – | 0.00% | 0.01% | 0.00% | 19.8% | -2.3% | -0.50% | – | – | – | – | – | – | – |
| Cost structure | ||||||||||||||
| R&D to revenue | – | – | – | 786.6% | 153.7% | 21.7% | – | – | – | – | – | – | – | – |
| Stock-based comp to revenue | – | – | – | 126.2% | 24.3% | 28.6% | – | – | – | – | – | – | – | – |
| Per employee | ||||||||||||||
| Total employees | 85 | 92 | 82 | 85 | 97 | 91 | 60 | 56 | 51 | 106 | 78 | 78 | 78 | 78 |
| Revenue per employee | – | – | $0 | $47.18K | $189.63K | $483.48K | $0 | $0 | – | – | – | – | – | – |
| Gross profit per employee | – | – | $0 | $39.52K | $129.63K | $103.84K | $0 | $0 | – | – | – | – | – | – |
| Operating profit per employee | -$655.12K | -$461.64K | -$457.44K | -$405.76K | -$258.58K | -$200.84K | -$520.55K | -$374.89K | -$667.82K | -$497.76K | -$480.90K | -$279.21K | -$127.24K | – |
| Net income per employee | -$535.76K | -$418.82K | -$299.48K | -$387.06K | -$179.53K | -$123.31K | $11.14M | -$377.46K | -$650.00K | -$497.75K | -$480.55K | -$278.51K | -$127.27K | – |
| Free cash flow per employee | -$473.05K | -$350.73K | -$232.77K | -$181.28K | $679.59K | -$756.88K | -$307.90K | -$297.48K | -$687.33K | -$478.88K | -$456.79K | -$167.91K | -$114.96K | – |
| Growth | ||||||||||||||
| Revenue 1Y growth | – | – | -100.0% | -78.2% | -58.2% | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | – | – | -100.0% | -73.3% | 33.1% | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -31.1% | -13.2% | -8.8% | -37.5% | -37.2% | 41.5% | -48.8% | 38.4% | 35.4% | -40.7% | -72.2% | -119.4% | – | – |
| Net income 1Y growth | -18.2% | -56.9% | 25.4% | -88.9% | -55.2% | -101.7% | 3,263.2% | 36.2% | 37.2% | -40.8% | -72.5% | -118.8% | – | – |
| Diluted EPS 1Y growth | -18.3% | -55.6% | 25.0% | -86.2% | -61.1% | -102.5% | 2,547.5% | 37.9% | 41.7% | -33.6% | -35.6% | -100.0% | – | – |
| Operating cash flow 1Y growth | -28.9% | -65.4% | -26.3% | -121.3% | 206.6% | -256.6% | -10.5% | 50.9% | 26.9% | -38.1% | -184.7% | -31.3% | – | – |
| Free cash flow 1Y growth | -24.6% | -69.1% | -23.9% | -123.4% | 195.7% | -272.8% | -10.9% | 52.5% | 30.9% | -42.5% | -172.0% | -46.1% | – | – |
| CapEx 1Y growth | -77.8% | 260.2% | -38.1% | -83.4% | -5.4% | 1,727.0% | 67.2% | -91.3% | -70.4% | 104.4% | 66.2% | 2,267.8% | – | – |
| CapEx 3Y CAGR | -20.9% | -28.2% | -54.0% | 42.1% | 206.9% | 38.4% | -65.0% | -62.5% | 0.19% | 331.7% | – | – | – | – |
| CapEx 5Y CAGR | -40.0% | 44.9% | 24.3% | -16.1% | -5.8% | 9.9% | -31.9% | 15.6% | – | – | – | – | – | – |
| CapEx 10Y CAGR | -18.8% | -0.69% | 19.9% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -24.6% | -12.1% | -7.9% | -10.6% | -22.2% | -56.7% | 1,742.1% | -29.6% | -6.1% | -38.7% | 75.9% | – | – | – |
| Total assets 3Y CAGR | -15.2% | -10.2% | -13.8% | -33.0% | 83.8% | 77.8% | 130.1% | -26.0% | 0.42% | – | – | – | – | – |
| Total assets 5Y CAGR | -15.8% | -24.6% | 38.6% | 31.3% | 32.6% | 26.5% | 67.4% | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | 3.2% | 12.3% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -23.0% | -16.7% | -9.0% | -10.8% | -22.7% | -53.9% | 1,725.3% | -31.2% | 1.9% | -42.7% | 74.6% | 477.1% | 38.7% | – |
| Total equity 3Y CAGR | -16.4% | -12.2% | -14.4% | -31.7% | 86.7% | 79.6% | 133.9% | -26.2% | 0.64% | 79.4% | 140.9% | – | – | – |
| Total equity 5Y CAGR | -16.6% | -24.8% | 39.5% | 31.9% | 35.5% | 27.6% | 66.5% | 32.3% | 52.2% | – | – | – | – | – |
| Total equity 10Y CAGR | 3.1% | 11.9% | 35.8% | 41.7% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.